172 related articles for article (PubMed ID: 8239902)
1. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. I. Characterization of biological properties of tumor lines and preliminary data on response to cytostatic drugs and biomodulators.
Fiszer-Maliszewska L; Mordarski M; Madej JA
Arch Immunol Ther Exp (Warsz); 1993; 41(1):1-9. PubMed ID: 8239902
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. II. Local interleukin 2 treatment of tumors of different immunogenic strength.
Fiszer-Maliszewska L; Den Otter W; Madej JA; Mordarski M
Arch Immunol Ther Exp (Warsz); 1998; 46(5):293-300. PubMed ID: 9832068
[TBL] [Abstract][Full Text] [Related]
3. Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.
Hosokawa M; Orsini F; Mihich E
Cancer Res; 1975 Oct; 35(10):2657-62. PubMed ID: 1157040
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of transplantable tumors in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent.
Pajtasz-Piasecka E; Kuśnierczyk H; Salwa J; Konarski L; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):281-92. PubMed ID: 8744648
[TBL] [Abstract][Full Text] [Related]
5. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength.
Fiszer-Maliszewska L; Den Otter W; Mordarski M
Cancer Immunol Immunother; 1999 Feb; 47(6):307-14. PubMed ID: 10203060
[TBL] [Abstract][Full Text] [Related]
6. [Changes in clonogenic properties of bone marrow and transplantable mice tumor cells during combined use of cyclophosphane and biological response modifiers of adaptogenic origin].
Udintsev SN; Shakhov VP
Eksp Onkol; 1990; 12(6):55-6. PubMed ID: 2261879
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenic properties of adenocarcinoma of mouse large intestine].
Avdeev GI; Svet-Moldavskaia IA; Khatuntseva NI; Kovaleva LP
Vopr Onkol; 1978; 24(3):72-7. PubMed ID: 644968
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effect of biological response modifiers in the "double grafted tumor system".
Ebina T; Kohya H; Yamaguchi T; Ishida N
Jpn J Cancer Res; 1986 Oct; 77(10):1034-42. PubMed ID: 3096919
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
[TBL] [Abstract][Full Text] [Related]
10. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
Huseby RA; Page RH
Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
[TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
13. Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.
Sobotkova E; Duskova M; Tachezy R; Petrackova M; Vonka V
Oncol Rep; 2009 Mar; 21(3):793-9. PubMed ID: 19212641
[TBL] [Abstract][Full Text] [Related]
14. Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.
Castillo R; Díaz JW; Veloso A; Gavilondo J
Neoplasma; 1982; 29(1):73-9. PubMed ID: 7070557
[TBL] [Abstract][Full Text] [Related]
15. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
17. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y
Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen.
Acres RB; Hareuveni M; Balloul JM; Kieny MP
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):136-43. PubMed ID: 8280702
[TBL] [Abstract][Full Text] [Related]
19. Generation of highly metastatic tumors in DBA/2 mice. Oncogenicity of a strain tumor cells.
Frost P; Kerbel RS; Tartamella-Biondo R
Invasion Metastasis; 1981; 1(1):22-33. PubMed ID: 7188380
[TBL] [Abstract][Full Text] [Related]
20. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
